Skip to main content
Top
Published in: Journal of General Internal Medicine 5/2014

01-05-2014 | Original Research

Financial Incentives for Home-Based Health Monitoring: A Randomized Controlled Trial

Authors: Aditi P. Sen, MA, Taylor B. Sewell, BS, E. Brooks Riley, BA, Beth Stearman, MPH, Scarlett L. Bellamy, ScD, Michelle F. Hu, MD, Yuanyuan Tao, MS, Jingsan Zhu, MBA, MS, James D. Park, MD, MPH, MSHP, George Loewenstein, PhD, David A. Asch, MD, MBA, Kevin G. Volpp, MD, PhD

Published in: Journal of General Internal Medicine | Issue 5/2014

Login to get access

ABSTRACT

BACKGROUND

Home wireless device monitoring could play an important role in improving the health of patients with poorly controlled chronic diseases, but daily engagement rates among these patients may be low.

OBJECTIVE

To test the effectiveness of two different magnitudes of financial incentives for improving adherence to remote-monitoring regimens among patients with poorly controlled diabetes.

DESIGN

Randomized, controlled trial. (Clinicaltrials.gov Identifier: NCT01282957).

PARTICIPANTS

Seventy-five patients with a hemoglobin A1c greater than or equal to 7.5 % recruited from a Primary Care Medical Home practice at the University of Pennsylvania Health System.

INTERVENTIONS

Twelve weeks of daily home-monitoring of blood glucose, blood pressure, and weight (control group; n = 28); a lottery incentive with expected daily value of $2.80 (n = 26) for daily monitoring; and a lottery incentive with expected daily value of $1.40 (n = 21) for daily monitoring.

MAIN MEASURES

Daily use of three home-monitoring devices during the three-month intervention (primary outcome) and during the three-month follow-up period and change in A1c over the intervention period (secondary outcomes).

KEY RESULTS

Incentive arm participants used devices on a higher proportion of days relative to control (81 % low incentive vs. 58 %, P = 0.007; 77 % high incentive vs. 58 %, P = 0.02) during the three-month intervention period. There was no difference in adherence between the two incentive arms (P = 0.58). When incentives were removed, adherence in the high incentive arm declined while remaining relatively high in the low incentive arm. In month 6, the low incentive arm had an adherence rate of 62 % compared to 35 % in the high incentive arm (P = 0.015) and 27 % in the control group (P = 0.002).

CONCLUSIONS

A daily lottery incentive worth $1.40 per day improved monitoring rates relative to control and had significantly better efficacy once incentives were removed than a higher incentive.
Literature
1.
go back to reference Asch DA, Muller RW, Volpp KG. Automated hovering in health care: watching over the 5,000 hours. N Engl J Med. 2012;367:1–3.PubMedCrossRef Asch DA, Muller RW, Volpp KG. Automated hovering in health care: watching over the 5,000 hours. N Engl J Med. 2012;367:1–3.PubMedCrossRef
3.
go back to reference Russell-Minda E, Jutai J, Speechley M, Bradley K, Chudyk A, Petrella R. Health technologies for monitoring and managing diabetes: a systematic review. J Diabetes Sci Technol. 2009;3(6):1460–71.PubMedCentralPubMedCrossRef Russell-Minda E, Jutai J, Speechley M, Bradley K, Chudyk A, Petrella R. Health technologies for monitoring and managing diabetes: a systematic review. J Diabetes Sci Technol. 2009;3(6):1460–71.PubMedCentralPubMedCrossRef
4.
go back to reference Goldberg LR, Piette JD, Walsh MN, et al. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J. 2003;146(4):705–12.PubMedCrossRef Goldberg LR, Piette JD, Walsh MN, et al. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J. 2003;146(4):705–12.PubMedCrossRef
5.
go back to reference Schwedes U, Siebolds M, Mertes G, SMBG Study Group. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care. 2002;25(11):1928–32.PubMedCrossRef Schwedes U, Siebolds M, Mertes G, SMBG Study Group. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care. 2002;25(11):1928–32.PubMedCrossRef
6.
go back to reference de Lusignan S, Wells S, Johnson P, Meredith K, Leatham E. Compliance and effectiveness of 1 year’s home telemonitoring. The report of a pilot study of patients with chronic heart failure. Eur J Heart Fail. 2001;3(6):723–30.PubMedCrossRef de Lusignan S, Wells S, Johnson P, Meredith K, Leatham E. Compliance and effectiveness of 1 year’s home telemonitoring. The report of a pilot study of patients with chronic heart failure. Eur J Heart Fail. 2001;3(6):723–30.PubMedCrossRef
7.
go back to reference Davidson MB, Castellanos M, Kain D, Duran P. The effect of self-monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005;118(4):422–5.PubMedCrossRef Davidson MB, Castellanos M, Kain D, Duran P. The effect of self-monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005;118(4):422–5.PubMedCrossRef
9.
go back to reference Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. JAMA. 2008;300(22):2631–7.PubMedCentralPubMedCrossRef Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. JAMA. 2008;300(22):2631–7.PubMedCentralPubMedCrossRef
11.
go back to reference Kimmel SE, Troxel AB, Loewenstein G, et al. Randomized trial of lottery-based incentives to improve warfarin adherence. Am Heart J. 2012;164(2):268–74.PubMedCrossRef Kimmel SE, Troxel AB, Loewenstein G, et al. Randomized trial of lottery-based incentives to improve warfarin adherence. Am Heart J. 2012;164(2):268–74.PubMedCrossRef
12.
go back to reference Asch DA, Volpp KG. On the Way to Health. LDI Issue Brief. July/August 2012. Volume 17, Issue 9. Asch DA, Volpp KG. On the Way to Health. LDI Issue Brief. July/August 2012. Volume 17, Issue 9.
13.
go back to reference Chapman GB, Coups EJ. Emotions and preventive health behavior: worry, regret, and influenza vaccination. Health Psychol. 2006;25(1):82–90.PubMedCrossRef Chapman GB, Coups EJ. Emotions and preventive health behavior: worry, regret, and influenza vaccination. Health Psychol. 2006;25(1):82–90.PubMedCrossRef
14.
go back to reference Zeelenberg M, Pieters R. Consequences of regret aversion in real life: the case of the Dutch postcode lottery. Organ Behav Hum Decis Process. 2004;93:155–68.CrossRef Zeelenberg M, Pieters R. Consequences of regret aversion in real life: the case of the Dutch postcode lottery. Organ Behav Hum Decis Process. 2004;93:155–68.CrossRef
15.
go back to reference Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979;47:263–91.CrossRef Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979;47:263–91.CrossRef
16.
go back to reference Connolly T, Butler DU. Regret in economic and psychological theories of choice. J Behav Decis Mak. 2006;19(2):148–58.CrossRef Connolly T, Butler DU. Regret in economic and psychological theories of choice. J Behav Decis Mak. 2006;19(2):148–58.CrossRef
17.
go back to reference Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.CrossRef Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.CrossRef
18.
go back to reference Zeger SL, Liang KY. The analysis of discrete and continuous longitudinal data. Biometrics. 1986;42:121–30.PubMedCrossRef Zeger SL, Liang KY. The analysis of discrete and continuous longitudinal data. Biometrics. 1986;42:121–30.PubMedCrossRef
19.
go back to reference Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–54.CrossRef Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–54.CrossRef
20.
go back to reference John LK, Loewenstein G, Troxel AB, Norton L, Fassbender JE, Volpp KG. Financial incentives for extended weight loss: a randomized, controlled trial. J Gen Intern Med. 2011;26(6):621–6.PubMedCentralPubMedCrossRef John LK, Loewenstein G, Troxel AB, Norton L, Fassbender JE, Volpp KG. Financial incentives for extended weight loss: a randomized, controlled trial. J Gen Intern Med. 2011;26(6):621–6.PubMedCentralPubMedCrossRef
21.
go back to reference Kullgren JT, Troxel AB, Loewenstein G, et al. Individual- versus group-based financial incentives for weight loss: a randomized, controlled trial. Ann Intern Med. 2013;158(7):505–14.PubMedCentralPubMedCrossRef Kullgren JT, Troxel AB, Loewenstein G, et al. Individual- versus group-based financial incentives for weight loss: a randomized, controlled trial. Ann Intern Med. 2013;158(7):505–14.PubMedCentralPubMedCrossRef
22.
go back to reference Eisenberger R, Cameron J. Detrimental effects of reward: reality or myth? Am Psychol. 1996;51(11):1153–66.PubMedCrossRef Eisenberger R, Cameron J. Detrimental effects of reward: reality or myth? Am Psychol. 1996;51(11):1153–66.PubMedCrossRef
23.
go back to reference Deci EL, Ryan RM. Intrinsic Motivation and Self-Determination in Human Behavior. New York, NY: Plenum Press; 1985.CrossRef Deci EL, Ryan RM. Intrinsic Motivation and Self-Determination in Human Behavior. New York, NY: Plenum Press; 1985.CrossRef
24.
go back to reference Lepper MR, Greene D, Nisbett RE. Undermining children’s intrinsic interest with extrinsic reward. J Pers Soc Psychol. 1973;28(1):129–37.CrossRef Lepper MR, Greene D, Nisbett RE. Undermining children’s intrinsic interest with extrinsic reward. J Pers Soc Psychol. 1973;28(1):129–37.CrossRef
25.
go back to reference Deci EL, Koestner R, Ryan RM. A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychol Bull. 1999;125(6):627–68.PubMedCrossRef Deci EL, Koestner R, Ryan RM. A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychol Bull. 1999;125(6):627–68.PubMedCrossRef
26.
go back to reference Gneezy U, Meier S, Rey-Biel P. When and why incentives (don’t) work to modify behavior. J Econ Perspect. 2011;25(4):1–21.CrossRef Gneezy U, Meier S, Rey-Biel P. When and why incentives (don’t) work to modify behavior. J Econ Perspect. 2011;25(4):1–21.CrossRef
Metadata
Title
Financial Incentives for Home-Based Health Monitoring: A Randomized Controlled Trial
Authors
Aditi P. Sen, MA
Taylor B. Sewell, BS
E. Brooks Riley, BA
Beth Stearman, MPH
Scarlett L. Bellamy, ScD
Michelle F. Hu, MD
Yuanyuan Tao, MS
Jingsan Zhu, MBA, MS
James D. Park, MD, MPH, MSHP
George Loewenstein, PhD
David A. Asch, MD, MBA
Kevin G. Volpp, MD, PhD
Publication date
01-05-2014
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 5/2014
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-014-2778-0

Other articles of this Issue 5/2014

Journal of General Internal Medicine 5/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.